Skip to main content

1.5 million doses of AstraZeneca vaccine to arrive from U.S.

#1321 of 1611 articles from the Special Report: Coronavirus in Canada
health worker, AstraZeneca/Oxford vaccine, Edouard Herriot hospital, France,
A health worker closes a door as she prepares doses of the AstraZeneca/Oxford vaccine at the Edouard Herriot hospital, on Saturday, Feb. 6, 2021 in Lyon, central France. File photo by Associated Press/Olivier Chassignole

Help us raise $150,000 by December 31

Goal: $150k
$5,000

The federal government is expecting around 1.5 million doses of the Oxford-AstraZeneca vaccine from the United States today.

The vaccines are expected to arrive by truck and represent the first to come from south of the border.

Provincial governments decide on their own how to use a vaccine, but Dr. Howard Njoo, Canada's deputy chief medical officer of health, says all provinces and territories have agreed to suspend the use of the vaccine for those under 55, pending the results of further study.

The province's are acting on an advisory committee's concerns about a possible link between the shot and rare blood clots.

Dr. Heather Morrison, P.E.I.'s chief medical officer of health, says the risk of developing a serious problem after being immunized is "very, very low."

The federal government is expecting around 1.5 million doses of the Oxford-AstraZeneca vaccine from the #UnitedStates today, March 30, 2021. #COVID19 #Covid19vaccine #AstraZeneca #CDNPoli

She says people who received the AstraZeneca vaccine should look for symptoms such as shortness of breath, chest pain, leg swelling, persistent abdominal pain, sudden onset of severe or persistent headache or blurred vision and skin bruising elsewhere than the site of vaccination, developing four to 20 days after getting the shot.

This report by The Canadian Press was first published March 30, 2021.

Comments